Neurocrine Bio. (NBIX) PT Lowered to $140 at BMO Capital

February 17, 2026 9:27 AM EST Send to a Friend

BMO Capital analyst Evan David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Neurocrine Bio. (NBIX) PT Lowered to $140 at BMO Capital

Member Login

Free News Feed